Core B-Specimen and Reagent Core
Core B-Specimen and Reagent Core
批准号:
9141191
负责人:
WUYUAN LU
金额:
$24.34万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-08-15 至 2020-07-31
关键词:
AccountabilityAcuteAntibodiesAntibody-mediated protectionAntigensArchivesBackBiologicalBiological AssayBiopsyCell LineCellsCommunitiesCore ProteinDataData QualityDatabasesEnsureFoundationsFundingGoalsGrantHIVHIV-1Macaca mulattaMonoclonal AntibodiesPassive ImmunizationPeptidesPeripheral Blood Mononuclear CellPlasmaPopulationPrimatesPrincipal InvestigatorProceduresProtein SubunitsProteinsQualifyingReagentResearchResearch PersonnelResourcesSamplingScheduleSourceSpecific qualifier valueSpecimenT-LymphocyteTestingVaccinatedWorkbaseenv Gene Productsprogramsquality assurancerectalsymposium
中文摘要
核心B的主要意义在于,它将为接收、跟踪、存储、
英文摘要
The principal significance of Core B is that it will provide a centralized source for the receipt, tracking, storage,
and distribution of valuable biological specimens generated by all three projects in addition to providing
standardized research reagents to the projects. This will be accomplished using established standard
operating procedures that are in place from our ongoing multi-project programs funded by grants from The Bill
and Melinda Gates Foundation. This strategy strengthens the quality of data across the projects and provides
a high-degree of accountability for quality assurance. In addition, Core B will archive both biological
specimens and test articles such as immunogens and mAbs used for passive immunization. These will be
used as needed by the three projects and they will be shared with the larger research community upon request
by other investigators. The three projects will have priority for receiving the specimens and test articles
required to accomplish their specific aims. The Principal Investigator and Project Leaders will determine
additional use of the specimens and test articles during regularly scheduled conference calls as specified in
Core A. In the case of acute need, the decision will be made by an ad hoc conference call. The same team
will establish priorities for external requests on an ad hoc basis for limited specimens or test articles. If the
request is not for a limited material, it will be honored pro forma. Core B will also work closely with Core A
where data will be archived to ensure that it can be readily tracked back to the specimens and test articles. The
goals of Core B will be achieved by two specific aims. Aim 1: Provide specimens from immunized and
challenged rhesus macaques. Aim 2: Provide antibody and protein reagents to the Program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Anticancer peptide therapeutics
-
批准号:9518796
-
项目类别:
-
资助金额:$35.34万
-
财政年份:2017
-
负责人:WUYUAN LU
-
依托单位:
Anticancer peptide therapeutics
-
批准号:9366543
-
项目类别:
-
资助金额:$35.34万
-
财政年份:2017
-
负责人:WUYUAN LU
-
依托单位:
D-peptide activators of p53 as anticancer therapeutics
-
批准号:8774207
-
项目类别:
-
资助金额:$16.69万
-
财政年份:2013
-
负责人:WUYUAN LU
-
依托单位:
D-peptide activators of p53 as anticancer therapeutics
-
批准号:8637246
-
项目类别:
-
资助金额:$20.03万
-
财政年份:2013
-
负责人:WUYUAN LU
-
依托单位:
High-throughput screening for HIV assembly and maturation inhibitors
-
批准号:8545199
-
项目类别:
-
资助金额:$28.14万
-
财政年份:2012
-
负责人:WUYUAN LU
-
依托单位:
High-throughput screening for HIV assembly and maturation inhibitors
-
批准号:8262517
-
项目类别:
-
资助金额:$29.17万
-
财政年份:2012
-
负责人:WUYUAN LU
-
依托单位:
High-throughput screening for HIV assembly and maturation inhibitors
-
批准号:8735972
-
项目类别:
-
资助金额:$29.17万
-
财政年份:2012
-
负责人:WUYUAN LU
-
依托单位:
D-peptide inhibitors of HIV assembly and maturation
-
批准号:8020942
-
项目类别:
-
资助金额:$18.56万
-
财政年份:2010
-
负责人:WUYUAN LU
-
依托单位:
Inhibition of Anthrax Lethal Factor by alpha-defensins
-
批准号:8134677
-
项目类别:
-
资助金额:$16.01万
-
财政年份:2010
-
负责人:WUYUAN LU
-
依托单位:
D-peptide inhibitors of HIV assembly and maturation
-
批准号:7929943
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2010
-
负责人:WUYUAN LU
-
依托单位:
Inhibition of Anthrax Lethal Factor by alpha-defensins
-
批准号:7557627
-
项目类别:
-
资助金额:$28.45万
-
财政年份:2006
-
负责人:WUYUAN LU
-
依托单位:
Inhibition of Anthrax Lethal Factor by alpha-defensins
-
批准号:7752142
-
项目类别:
-
资助金额:$50.5万
-
财政年份:2006
-
负责人:WUYUAN LU
-
依托单位:
Inhibition of Anthrax Lethal Factor by alpha-defensins
-
批准号:7753236
-
项目类别:
-
资助金额:$36.42万
-
财政年份:2006
-
负责人:WUYUAN LU
-
依托单位:
Inhibition of Anthrax Lethal Factor by alpha-defensins
-
批准号:7992414
-
项目类别:
-
资助金额:$36.06万
-
财政年份:2006
-
负责人:WUYUAN LU
-
依托单位:
Inhibition of Anthrax Lethal Factor by alpha-defensins
-
批准号:7329150
-
项目类别:
-
资助金额:$36.79万
-
财政年份:2006
-
负责人:WUYUAN LU
-
依托单位:
Inhibition of Anthrax Lethal Factor by alpha-defensins
-
批准号:7187528
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2006
-
负责人:WUYUAN LU
-
依托单位:
Molecular Basis of Human Neutrophil alpha-Defensin Function
-
批准号:7173729
-
项目类别:
-
资助金额:$8.05万
-
财政年份:2005
-
负责人:WUYUAN LU
-
依托单位:
Molecular Basis of Human Neutrophil a-Defensin Function
-
批准号:7559544
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2005
-
负责人:WUYUAN LU
-
依托单位:
Molecular Basis of Human Neutrophil a-Defensin Function
-
批准号:7009064
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2005
-
负责人:WUYUAN LU
-
依托单位:
Molecular Basis-Human Neutrophil alpha-Defensin Function
-
批准号:6902252
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2005
-
负责人:WUYUAN LU
-
依托单位:
海外基金